Skip to main content
Figure 1 | BMC Public Health

Figure 1

From: Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model

Figure 1

Probabilistic sensitivity analysis (A) results for the HPV-16/18 vaccine vs. screening as comparator, (6% discount on costs and health outcomes) (B) results for the HPV-6/11/16/18 vaccine vs. screening as comparator (6% discount on costs and health outcomes) and (C) results for the HPV-16/18 vaccine vs. HPV-6/11/16/18 vaccine used as comparator (6% discount on costs and health outcomes).

Back to article page

BMC Public Health

ISSN: 1471-2458

Contact us